These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 33212091)

  • 21. Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.
    Paterson YZ; Rash N; Garvican ER; Paillot R; Guest DJ
    Stem Cell Res Ther; 2014 Jul; 5(4):90. PubMed ID: 25080326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the relationship between mesenchymal stem cells and immune system in vitro conditions.
    Erol A; Sel FA; Süleymanoğlu M; Demirayak G; Kuruca DS; Savran Oğuz F
    Mol Biol Rep; 2023 May; 50(5):4347-4356. PubMed ID: 36935445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation.
    Cutler AJ; Limbani V; Girdlestone J; Navarrete CV
    J Immunol; 2010 Dec; 185(11):6617-23. PubMed ID: 20980628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6.
    Najar M; Rouas R; Raicevic G; Boufker HI; Lewalle P; Meuleman N; Bron D; Toungouz M; Martiat P; Lagneaux L
    Cytotherapy; 2009; 11(5):570-83. PubMed ID: 19565371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use.
    Torrents S; Del Moral AE; Codinach M; Rodríguez L; Querol S; Vives J
    Immunol Res; 2023 Oct; 71(5):725-734. PubMed ID: 37120479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.
    Saka Y; Furuhashi K; Katsuno T; Kim H; Ozaki T; Iwasaki K; Haneda M; Sato W; Tsuboi N; Ito Y; Matsuo S; Kobayashi T; Maruyama S
    Xenotransplantation; 2011; 18(3):196-208. PubMed ID: 21696449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
    Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells.
    Samuelsson H; Ringdén O; Lönnies H; Le Blanc K
    Cytotherapy; 2009; 11(2):129-36. PubMed ID: 19152151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human adipose tissue-derived mesenchymal stem cells in rheumatoid arthritis: Regulatory effects on peripheral blood mononuclear cells activation.
    Baharlou R; Ahmadi-Vasmehjani A; Faraji F; Atashzar MR; Khoubyari M; Ahi S; Erfanian S; Navabi SS
    Int Immunopharmacol; 2017 Jun; 47():59-69. PubMed ID: 28364628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
    Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
    Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis.
    Baharlooi H; Nouraei Z; Azimi M; Moghadasi AN; Tavassolifar MJ; Moradi B; Sahraian MA; Izad M
    Scand J Immunol; 2021 Jun; 93(6):e13013. PubMed ID: 33338274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tonsil-derived mesenchymal stem cells exert immunosuppressive effects on T cells.
    Bačić A; Prgomet D; Janjanin S
    Croat Med J; 2019 Feb; 60(1):12-19. PubMed ID: 30825273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential.
    Rizzo R; Lanzoni G; Stignani M; Campioni D; Alviano F; Ricci F; Tazzari PL; Melchiorri L; Scalinci SZ; Cuneo A; Bonsi L; Lanza F; Bagnara GP; Baricordi OR
    Cytotherapy; 2011 May; 13(5):523-7. PubMed ID: 21171826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
    Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
    Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesicles.
    Bremer M; Nardi Bauer F; Tertel T; Dittrich R; Horn PA; Börger V; Giebel B
    Cytotherapy; 2023 Aug; 25(8):847-857. PubMed ID: 37097266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge.
    Boland LK; Burand AJ; Boyt DT; Dobroski H; Di L; Liszewski JN; Schrodt MV; Frazer MK; Santillan DA; Ankrum JA
    Front Immunol; 2019; 10():1080. PubMed ID: 31134100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton's jelly of umbilical cord on PBMCs.
    Ayatollahi M; Talaei-Khozani T; Razmkhah M
    Iran J Basic Med Sci; 2016 Feb; 19(2):145-53. PubMed ID: 27081458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells.
    Oh W; Kim DS; Yang YS; Lee JK
    Cell Immunol; 2008 Feb; 251(2):116-23. PubMed ID: 18495100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.